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• Brinkhaus B, Ortiz M,  Witt CM,  Roll S, Linde K, Pfab F, et al.
Acupuncture in patients with seasonal allergic rhinitis: a
randomized trial. Ann Intern Med  2013;158(4):225-34.
Background: Acupuncture is frequently used to treat sea-
sonal allergic rhinitis (SAR) despite limited scientiﬁc evidence.
Objective: To evaluate the effects of acupuncture in patients
with SAR.
Design: Randomized, controlled multicenter trial. (Clinical-
Trials.gov: NCT00610584) SETTING: 46 specialized physicians
in 6 hospital clinics and 32 private outpatient clinics.
Patients: 422 persons with SAR and IgE sensitization to birch
and grass pollen.
Intervention: Acupuncture plus rescue medication (RM) (cet-
irizine) (n = 212), sham acupuncture plus RM (n = 102), or RM
alone (n = 108). Twelve treatments were provided over 8 weeks
in the ﬁrst year.
Measurements: Changes in the Rhinitis Quality of Life Ques-
tionnaire (RQLQ) overall score and the RM score (RMS) from
baseline to weeks 7 and 8 and week 16 in the ﬁrst year and
week 8 in the second year after randomization, with pre-
deﬁned noninferiority margins of -0.5 point (RQLQ) and -1.5
points (RMS).
Results: Compared with sham acupuncture and with RM,
acupuncture was associated with improvement in RQLQ score
(sham vs. acupuncture mean difference, 0.5 point [97.5% CI,
0.2 to 0.8 point; P < 0.001]; RM vs. acupuncture mean differ-
ence, 0.7 point [97.5% CI, 0.4 to 1.0 point; P < 0.001]) and RMS
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(sham vs. acupuncture mean difference, 1.1 points [97.5% CI,
0.4 to 1.9 points; P < 0.001]; RM vs. acupuncture mean differ-
ence, 1.5 points [97.5% CI, 0.8 to 2.2 points; P < 0.001]). There
were no differences after 16 weeks in the ﬁrst year. After the
8-week follow-up phase in the second year, small improve-
ments favoring real acupuncture over the sham procedure
were noted (RQLQ mean difference, 0.3 point [95% CI, 0.03 to
0.6 point; P = 0.032]; RMS mean difference, 1.0 point [95% CI,
0.2 to 1.9 points; P = 0.018]).
Limitation: The study was not powered to detect rare
adverse events, and the RQLQ and RMS values were low at
baseline.
Conclusion: Acupuncture led to statistically signiﬁcant
improvements in disease-speciﬁc quality of life and antihis-
tamine use measures after 8 weeks of treatment compared
with sham acupuncture and with RM alone, but the improve-
ments may not be clinically signiﬁcant.
• Choi SM,  Park JE, Li SS, Jung H, Zi M, Kim TH et al. A mul-
ticenter, randomized, controlled trial testing the effects of
acupuncture on allergic rhinitis. Allergy 2013;68(3):365-74.
Background: The aim of this study was to evaluate the efﬁ-
cacy and safety of acupuncture in the treatment for allergic
rhinitis.
Methods: This study was a multicenter, randomized,
parallel-controlled study. Participants were randomized to
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either the active acupuncture, sham acupuncture, or waitlist
groups. The active and sham acupuncture groups received
acupuncture treatment three times per week for 4 weeks.
In the sham group, minimal acupuncture at nonacupunc-
ture points was used. The waitlist group did not receive any
acupuncture treatment.
Results: Of the 238 participants, 97, 94, and 47 individuals
were assigned to the active acupuncture, sham acupuncture,
and waitlist group, respectively. After the treatment, the differ-
ence in the total nasal symptom score (TNSS) was signiﬁcantly
reduced in the active acupuncture group compared with the
sham acupuncture (difference: -1.03, 95% conﬁdence interval
[CI]: -1.96, -0.09, P = 0.03) and waitlist (difference: -2.49, 95% CI:
-3.68, -1.29, P < 0.0001). The active acupuncture group exhib-
ited a signiﬁcant change in the total non-nasal symptom score
(TNNSS) compared with the waitlist (difference: -0.78, 95% CI:
-1.22, -0.34, P = 0.0002), but not the sham acupuncture group
(difference; 0.15, 95% CI: -0.21, 0.5, P = 0.56). Both active and
sham acupuncture treatments resulted in signiﬁcant improve-
ments in TNSS and TNNSS compared to baseline.
Conclusion: Active acupuncture showed a signiﬁcantly
greater effect on symptoms of allergic rhinitis than either
sham acupuncture or no active treatment. The symptoms
of allergic rhinitis decreased signiﬁcantly after treatment
in the both acupuncture and sham acupuncture groups.
Acupuncture appears to be an effective and safe treatment
for allergic rhinitis.
• Chae Y, Chang DS, Lee SH, Jung WM,  Lee IS, Jackson S, et al.
Inserting needles into the body: a meta-analysis of brain
activity associated with acupuncture needle stimulation. J
Pain 2013;14(3):215-22.
Acupuncture is a therapeutic treatment that is deﬁned
as the insertion of needles into the body at speciﬁc points
(ie, acupoints). Advances in functional neuroimaging have
made it possible to study brain responses to acupuncture;
however, previous studies have mainly concentrated on
acupoint speciﬁcity. We wanted to focus on the functional
brain responses that occur because of needle insertion into
the body. An activation likelihood estimation meta-analysis
was carried out to investigate common characteristics of
brain responses to acupuncture needle stimulation compared
to tactile stimulation. A total of 28 functional magnetic res-
onance imaging studies, which consisted of 51 acupuncture
and 10 tactile stimulation experiments, were selected for the
meta-analysis. Following acupuncture needle stimulation,
activation in the sensorimotor cortical network, including the
insula, thalamus, anterior cingulate cortex, and primary and
secondary somatosensory cortices, and deactivation in the
limbic-paralimbic neocortical network, including the medial
prefrontal cortex, caudate, amygdala, posterior cingulate
cortex, and parahippocampus, were detected and assessed.
Following control tactile stimulation, weaker patterns of
brain responses were detected in areas similar to those stated
above. The activation and deactivation patterns following
acupuncture stimulation suggest that the hemodynamic
responses in the brain simultaneously reﬂect the sensory,
cognitive, and affective dimensions of pain. PERSPECTIVE:
This article facilitates a better understanding of acupuncture
needle stimulation and its effects on speciﬁc activity changes
in different brain regions as well as its relationship to the
multiple dimensions of pain. Future studies can build on
this meta-analysis and will help to elucidate the clinically
relevant therapeutic effects of acupuncture.
• Vickers AJ, Cronin AM, Maschino AC, Lewith G, MacPher-
son H, Foster NE, et al. Acupuncture for chronic pain:
individual patient data meta-analysis. Arch Intern Med
2012;172(19):1444-53.
Background: Although acupuncture is widely used for
chronic pain, there remains considerable controversy as to its
value. We aimed to determine the effect size of acupuncture
for 4 chronic pain conditions: back and neck pain, osteoarthri-
tis, chronic headache, and shoulder pain.
Methods: We conducted a systematic review to iden-
tify randomized controlled trials (RCTs) of acupuncture for
chronic pain in which allocation concealment was determined
unambiguously to be adequate. Individual patient data meta-
analyses were conducted using data from 29 of 31 eligible
RCTs, with a total of 17 922 patients analyzed.
Results: In the primary analysis, including all eligible RCTs,
acupuncture was superior to both sham and no-acupuncture
control for each pain condition (P < .001 for all comparisons).
After exclusion of an outlying set of RCTs that strongly favored
acupuncture, the effect sizes were similar across pain con-
ditions. Patients receiving acupuncture had less pain, with
scores that were 0.23 (95% CI, 0.13-0.33), 0.16 (95% CI, 0.07-
0.25), and 0.15 (95% CI, 0.07-0.24) SDs lower than sham controls
for back and neck pain, osteoarthritis, and chronic headache,
respectively; the effect sizes in comparison to no-acupuncture
controls were 0.55 (95% CI, 0.51-0.58), 0.57 (95% CI, 0.50-0.64),
and 0.42 (95% CI, 0.37-0.46) SDs. These results were robust
to a variety of sensitivity analyses, including those related to
publication bias.
Conclusions: Acupuncture is effective for the treatment of
chronic pain and is therefore a reasonable referral option.
Signiﬁcant differences between true and sham acupuncture
indicate that acupuncture is more  than a placebo. However,
these differences are relatively modest, suggesting that
factors in addition to the speciﬁc effects of needling are
important contributors to the therapeutic effects of acupunc-
ture.
• Shah GR, Chaudhari MV, Patankar SB, Pensalwar SV,
Sabale VP, Sonawane NA. Evaluation of a multi-herb
supplement for erectile dysfunction: a randomized double-
blind, placebo-controlled study. BMC  Complement Altern Med
2012;12:155.
Backgroud: Evidence is lacking for multi-ingredient
herbal supplements claiming therapeutic effect in sexual
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dysfunction in men. We examined the safety and efﬁcacy
of VigRX Plus (VXP) - a proprietary polyherbal preparation
for improving male sexual function, in a double blind, ran-
domized placebo-controlled, parallel groups, multi-centre
study.
Methods: 78 men  aged 25-50 years of age; suffering from
mild to moderate erectile dysfunction (ED), participated in this
study. Subjects were randomized to receive VXP or placebo
at a dose of two capsules twice daily for 12 weeks. The
international index of erectile function (IIEF) was the pri-
mary  outcome measure of efﬁcacy. Other efﬁcacy measures
were: Erectile Dysfunction Inventory of Treatment Satisfaction
(EDITS), Serum testosterone, Semen analysis, Investigator’s
Global assessment and Subjects’ opinion.
Results: In subjects receiving VXP, the IIEF-Erectile Func-
tion (EF) scores improved signiﬁcantly as compared to placebo.
After 12 weeks of treatment, the mean (sd) IIEF-EF score at
baseline increased from 16.08 (2.87) to 25.08 (4.56) in the
VXP group versus 15.86 (3.24) to 16.47 (4.25) in the placebo
group (P < 0.0001). Similar results were observed in each of
the remaining four domains of the IIEF (orgasmic function,
sexual desire, intercourse satisfaction, and overall satisfac-
tion).There was a signiﬁcant difference for VXP versus placebo
comparison of mean (sd) EDITS scores of patients: 82.31(20.23)
vs 36.78(22.53) and partners:(82.75(9.8) vs 18.50(9.44);P < 0.001.
Thirty-ﬁve out of 39 (90%) subjects from the VXP group
and one (3%) from the placebo group wished to continue
with the treatment they received. Investigator’s global assess-
ment rated VXP therapy as very good to excellent in more
than 50% patients and placebo therapy as fair to good in
about 25% of patients. Incidence of side effects and sub-
ject’s rating for tolerability of treatment was similar in both
groups.
Conclusions: VigRX Plus was well tolerated and more  effec-
tive than placebo in improving sexual function in men.
• Lee NH, Yoo SR, Kim HG, Cho JH, Son CG. Safety and
tolerability of Panax ginseng root extract: a randomized,
placebo-controlled, clinical trial in healthy Korean volun-
teers. J Altern Complement Med  2012;18(11):1061-9.
Objectives: Panax ginseng has been extensively used as an
adaptogen and is among the top 10 selling herbal supplements
in the United States over the past decade. However, there have
been few reports about the toxicity of P. ginseng in human
studies. Given the lack of toxicological studies in human, this
study investigated whether P. ginseng administration causes
any noticeable toxic effects in healthy volunteers.
Methods: This study was designed as a randomized, double-
blind, placebo-controlled, and parallel group trial in healthy
volunteers. The subjects were required to be healthy, free from
any signiﬁcant disease, as assessed at screening by physical
examination, medical history, and laboratory (hematological
and biochemical) tests. Eligible subjects received P. ginseng
extract (1 g/day or 2 g/day) or placebo over a 4-week period.
Results: Although mild adverse events, such as dyspepsia,
hot ﬂash, insomnia, and constipation, were reported in both
P. ginseng and placebo group, no serious untoward reactions
were reported following P. ginseng administration. Nonsigniﬁ-
cant changes were observed in hematological and biochemical
tests.
Conclusions: P. ginseng administration for 4 weeks was
shown to be safe, tolerable, and free of any untoward toxic
effect in healthy male and female volunteers. Future results
from ongoing multicenter collaborative efforts to evaluate
short- and long-term effects of P. ginseng may contribute to
our current understanding of safety and tolerability of this
herbal product.
• Schmid AA, Van Puymbroeck M, Altenburger PA, Schalk
NL, Dierks TA, Miller KK, et al. Poststroke balance improves
with yoga: a pilot study. Stroke 2012;43(9):2402-7
Background and purpose: Balance impairment is com-
mon  after stroke; modiﬁed yoga may be able to improve
balance and other important poststroke variables. Scientiﬁc-
evidence is needed to support such treatment interventions.
The purpose of this study was to assess the impact of a
yoga-based rehabilitation intervention on balance, balance
self-efﬁcacy, fear of falling (FoF), and quality of life after
stroke.
Methods: This was a prospective, randomized, pilot study
of yoga-based rehabilitation for people with chronic stroke.
All yoga sessions were taught by a registered yoga therapist,
occurred twice per week for 8 weeks and included seated,
standing, and ﬂoor postures with relaxation and meditation.
Balance was assessed with the Berg Balance Scale, balance
self-efﬁcacy with the Activities-speciﬁc Balance Conﬁdence
Scale, FoF with a dichotomous yes/no question, and quality
of life with the Stroke Speciﬁc Quality of Life scale.
Results: There were no signiﬁcant differences between wait-
list control (n = 10) and yoga (n = 37) groups in baseline or
follow-up scores. However, using within-group comparisons,
yoga group data demonstrated signiﬁcant improvement in
balance (Berg Balance Scale, 41.3 ± 11.7 vs 46.3 ± 9.1; P < 0.001)
and FoF (51% vs 46% with FoF; P < 0.001).
Conclusions: A group yoga-based rehabilitation intervention
for people with chronic stroke has potential in improving
multiple poststroke variables. Group yoga may be comple-
mentary to rehabilitation, may be possible in medical-based
and community-based settings, and may be cost-effective.
Further testing of group yoga-based rehabilitation inter-
ventions is warranted. Clinical Trial Registration- URL:
http://clinicaltrials.gov. Unique Identiﬁer: NCT01109602.
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